Let’s Talk Lows
Editor’s Note: This week, Beyond Type 1 will be focusing on hypoglycemia and severe hypoglycemia during our ‘Let’s Talk Lows’ campaign. We’re looking at causes, symptoms, fears and treatment options. Follow along using the hashtag #LetsTalkLows and share your hypoglycemia experiences with the community.
Let’s Talk Lows with BT1
In this causal conversation we discussed some of our scarier hypo experiences, sharing what we wish people knew about low blood sugars, and the changing the way we think about treatment options.
Let’s Talk Lows with Dr. Anne Peters
Dr. Peters discusses some of the barriers to obtaining glucagon, when to use in an emergency situation, and how newer formulations are making it easier than ever to train loved ones how to use.
My 10-Year Old Can Save My LifeAnyone familiar with Type 1 Diabetes has heard the term hypo or low when discussing blood glucose levels. And, whether you are someone with T1D or someone who cares for a T1D, chances are you have bee...MORE
Hypoglycemia ConfessionsI would like to say that I can limit myself to 15g of glucose, but the truth is, when I have a low bloodsugar, things get crazy.MORE
Untreatable: My Life With Chronic Sustained LowsI know this is terrifying. I take it extremely seriously. My situation is complicated, mysterious, and in many ways dire. It’s something that I’m learning to process and handle as I grow with it.MORE
Crashing Low While Riding Up — A Chairlift Emergency"I have been low on chairlift rides many times and I have used glucagon in an emergency twice… but I have only ever had one scary low while on a chairlift."MORE
Climbing Mountains and Surviving LowsMichael Gaudet, a chemical engineer by trade, an avid mountaineer and senior instructor at the Colorado Mountain Club, has used glucagon numerous times.MORE
The Words We Use When Talking About LowsRenza recounts learning about lows following her diagnosis with T1D, a scary encounter with severe hypoglycemia, and the words we use to describe hypos.MORE
Educational content related to severe hypoglycemia is made possible with support from Lilly Diabetes (BAQSIMI), and editorial control rests solely on Beyond Type 1.